Literature DB >> 5056115

Idiopathic orthostatic hypotension treated with levodopa and MAO inhibitor: a preliminary report.

J Sharpe, A Marquez-Julio, P Ashby.   

Abstract

The clinical and pathophysiological features of a case of idiopathic orthostatic hypotension (Shy-Drager syndrome) are presented. Recent reports on the pathological findings in this condition indicate that there may be a defect in catecholamine synthesis in the pigmented brain stem nuclei and sympathetic ganglia similar to that in idiopathic parkinsonism. On this basis a new form of therapy using levodopa combined with MAO inhibition is derived. The results of a trial of this therapy, which produced improvements in both the hypotension and in the extrapyramidal features of the disease, are reported.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5056115      PMCID: PMC1940744     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  34 in total

1.  Improvement in methodology for measurement of plasma renin activity.

Authors:  R Boucher; J Genest
Journal:  Can J Physiol Pharmacol       Date:  1966-01       Impact factor: 2.273

2.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

3.  [Anatomoclinical study of a case of "idiopathic" orthostatic hypotension. Pathogenic considerations].

Authors:  J P Fichefet; J E Sternon; L Franken; J C Demanet; J J Vanderhaeghen
Journal:  Acta Cardiol       Date:  1965       Impact factor: 1.718

4.  Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy.

Authors:  J G Graham; D R Oppenheimer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-02       Impact factor: 10.154

5.  Idiopathic orthostatic hypotension. Report of successful treatment with a new form of therapy.

Authors:  R H Seller
Journal:  Am J Cardiol       Date:  1969-06       Impact factor: 2.778

6.  The orthostatic hypotension syndrome of Shy-Drager. A clinicopathologic report.

Authors:  G A Schwarz
Journal:  Arch Neurol       Date:  1967-02

7.  Defective autonomic control of blood vessels in idiopathic orthostatic hypotension.

Authors:  R Bannister; L Ardill; P Fentem
Journal:  Brain       Date:  1967-12       Impact factor: 13.501

Review 8.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

9.  Renin-aldosterone system in Parkinson's disease.

Authors:  A Barbeau; L Gillo-Joffroy; R Boucher; W Nowaczynski; J Genest
Journal:  Science       Date:  1969-07-18       Impact factor: 47.728

10.  Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).

Authors:  F McDowell; J E Lee; T Swift; R D Sweet; J S Ogsbury; J T Kessler
Journal:  Ann Intern Med       Date:  1970-01       Impact factor: 25.391

View more
  3 in total

1.  Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Authors:  J R Bianchine; L Sunyapridakul
Journal:  Drugs       Date:  1973       Impact factor: 9.546

2.  Plasma catecholamines during activation of the sympathetic nervous system in a patient with Shy-Drager syndrome.

Authors:  G Gross; M Nagel-Hiemke; K H Krause
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

3.  Anaesthetic considerations in idiopathic orthostatic hypotension and the Shy-Drager syndrome.

Authors:  M D Malan; R R Crago
Journal:  Can Anaesth Soc J       Date:  1979-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.